Current Studies

Scythian Biosciences: Cannabinoid-based concussion treatment (2016-2021)

This five-year partnership with Scythian Biosciences will assess the effectiveness of a new cannabinoid-based pill to treat concussion injuries. Theis partnership aims to propel this research and potential treatment forward by using two classes of drugs in a combination that scientists believe will reduce brain inflammation and the immune response. Learn more at UM News.

NCAA CARE Consortium Study (2016)

This study, led by the University of Michigan, provides a prospective, multi-institution clinical research protocol whose aim will be to study the natural history of concussions among NCAA student athletes.

GE Healthcare & BrainScope: Advanced MRI Applications for mTBI Phase 2 (2015)

The GE Healthcare project is a multi-site perspective study, evaluating mTBI injuries through cognitive testing and MRIs to further understand how concussions affect the brain. BrainScope is a companion study to the GE Phase 2 project, designed to collect and share post-mTBI data with other researchers using BrainScope's EEG device.

Track TBI

In partnership with 11 other U.S. sites, the NINDS-funded Track TBI study collects and analyzes detailed clinical data on 3000 subjects across the injury spectrum, along with CT/MRI imaging, blood biospecimens, and detailed clinical outcomes.

Our Partners